Option Care Health, Inc. (OPCH)
Healthcare
- Fundamental
- 4
- Sentiment
- 2
- Technical
- 3
Do Nothing: qualitativeScore is 2 (below required floor of 3); strategy requires qualitativeScore ≥ 3 before any bullish entry. All other Step 00 gates passed (price ceiling, fundamental floor, overnight-gap, recent liquidity, indicator integrity, holding-window events, minimum ATR, fresh feed).
Company overview
Option Care Health, Inc. provides home infusion services across the United States, offering specialized treatments for infections, heart failure, and nutritional support. The company also manages therapies for immune deficiencies, chronic inflammatory disorders, neurological conditions, and high-risk pregnancies, alongside professional nursing services.
Fundamental
goodOption Care Health shows solid profitability and valuation, but growth deceleration and reimbursement risks limit its top-tier score.
FundamentalScore 4/5: profitable, cash-generative home-infusion provider with moderate leverage and attractive valuation (EV/Sales ~0.81; FCF yield ~9.80%). Recent SEC filings show solid liquidity and no going-concern or covenant issues, but 2026 revenue growth is slowing and reimbursement/payer dynamics remain the key fundamental risk.
Sentiment
weakSentiment is stable with no actionable catalysts or significant retail interest.
Absent setup with a quiet catalyst calendar: the only in-window coverage is routine consensus-Hold and valuation commentary recycling the fully digested Q2 2026 beat, so nothing actionable is on the 1–30 day tape; sentiment delta is determinate and flat-to-slightly-positive (baseline +0.05 vs scoring on-topic items +0.2/+0.3), retail is indeterminate at zero threads, and the Red-Flag Screen is clean.
Technical
fairThe stock is range-bound with stalled momentum, offering no clear technical entry point.
Mixed chart: price $23.88 is above the SMA20 (23.90) and SMA50 (23.29) but below the SMA200 (26.89); the near-term EMA stack (EMA9 24.05 / EMA21 23.87) is flat and pinched around price. Momentum is stalling — RSI14 52.5 neutral, Williams %R -55.2 neutral, MACD line barely positive (0.22) with a slightly negative histogram (-0.01), and ADX14 11.5 confirming a trendless consolidation rather than an emerging trend. Liquidity is ample (20-day avg dollar volume $49.4M). Score 3 reflects the mixed-to-neutral read; the trade itself is hard-blocked upstream by the qualitative override (qualitativeScore 2 < 3), so no entry was evaluated.
You’re looking at 2026-09-21 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.